Tuesday, October 27, 2009

Industry Years Behind on Testing Approved Drugs


---------- Forwarded message ----------
From: barry levine 
Date: Tue, Oct 27, 2009 at 10:13 AM
Subject: re: Industry Years Behind on Testing Approved Drugs
To: letters@nytimes.com

To the Editor:
    Once a therapy has been approved for market, a drug company has scant incentive to complete further ("Phase IV") testing that might show risks of inefficacy.  All the incentives are in the wrong direction. Better to take clinical trials out of industry's hands entirely. Let a third party or the FDA conduct and analyse clinical trials that the drug companies have designed. The current honor system pits the public interest against human nature.
Barry Levine 

No comments: